Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions

Levetiracetam 1000 mg Under Fasting Conditions

NCT00859521 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

NCT01132352 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

NCT01618877 ·Status: COMPLETED ·Phase: PHASE1

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

NCT00946751 ·Status: COMPLETED ·Phase: PHASE1

A Bioequivalence Study of Levetiracetam Versus Keppra

NCT00926302 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

NCT01394224 ·Status: COMPLETED ·Phase: PHASE1

Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

NCT00150735 ·Status: COMPLETED ·Phase: PHASE3

Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.

NCT01131897 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions

NCT06762743 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

NCT00150748 ·Status: COMPLETED ·Phase: PHASE3

Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

NCT00150813 ·Status: COMPLETED ·Phase: PHASE3

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

NCT00150787 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

NCT01506882 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

NCT00362141 ·Status: UNKNOWN ·Phase: PHASE2

A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)

NCT00247364 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

NCT01392768 ·Status: COMPLETED ·Phase: PHASE3

Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy

NCT00175903 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

NCT00280696 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

NCT00610454 ·Status: COMPLETED ·Phase: PHASE2

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

NCT01228747 ·Status: COMPLETED ·Phase: PHASE3

Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

NCT01954121 ·Status: COMPLETED ·Phase: PHASE3

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

NCT00367432 ·Status: COMPLETED ·Phase: PHASE3

Levetiracetam for Painful Polyneuropathy

NCT00286260 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

NCT00736931 ·Status: COMPLETED ·Phase: PHASE1

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

NCT02726867 ·Status: WITHDRAWN ·Phase: PHASE3